<DOC>
	<DOC>NCT01143207</DOC>
	<brief_summary>A single-arm trial to demonstrate that Depo-SubQ Provera injected in the upper arm is adequate for effective contraception</brief_summary>
	<brief_title>PK of Depo SubQ Injected in the Upper Arm</brief_title>
	<detailed_description>A single-arm trial to demonstrate that the blood levels of medroxyprogesterone acetate are adequate for effective contraception when Depo-SubQ Provera 104 is injected in the upper arm</detailed_description>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<criteria>Age 1840 negative pregnancy test on day of injection not wishing to become pregnant in the next 12 months at negligible risk of pregnancy (e.g. sterilized, in exclusively samegender partnership, in a monogamous relationship with vasectomized partner, abstinent, using nonhormonal IUD) body mass index of 1830</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>AE adverse event</keyword>
	<keyword>DCF data collection forms</keyword>
	<keyword>DMC Data Monitoring Committee</keyword>
	<keyword>FDA U.S.) Food and Drug Administration</keyword>
	<keyword>GCP Good Clinical Practice guidelines</keyword>
	<keyword>ICH International Conference of Harmonisation</keyword>
	<keyword>IND Investigational New Drug Application</keyword>
	<keyword>IRB Institutional Review Board</keyword>
	<keyword>IU International units</keyword>
	<keyword>mg milligram(s)</keyword>
	<keyword>SAE serious adverse event</keyword>
	<keyword>Âµg microgram</keyword>
	<keyword>ULN upper limit of the normal range</keyword>
</DOC>